We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Clinical differentiation of severe acute respiratory syndrome coronavirus 2 pneumonia using the Japanese guidelines.
- Authors
Miyashita, Naoyuki; Nakamori, Yasushi; Ogata, Makoto; Fukuda, Naoki; Yamura, Akihisa; Ishiura, Yoshihisa; Nomura, Shosaku
- Abstract
Keywords: coronavirus disease; COVID-19; pneumonia; SARS-CoV-2; severe acute respiratory syndrome coronavirus 2 EN coronavirus disease COVID-19 pneumonia SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 90 92 3 01/18/22 20220101 NES 220101 The coronavirus disease 2019 (COVID-19) pandemic, caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a sudden and substantial increase in hospitalizations for pneumonia worldwide.1 Although the reverse transcription PCR assay is a commonly used tool for the diagnosis of COVID-19, the sensitivity of PCR is not high using oropharyngeal and nasopharyngeal swab specimens and depends on the time of collection and the collector.2,3 The Japanese Respiratory Society (JRS) scoring system, consisting of six parameters, is a useful tool for the early presumptive diagnosis of mild-to-moderate atypical pneumonia, mainly I Mycoplasma pneumoniae i pneumonia.4 These parameters were: (1) age < 60 years, (2) no or minor comorbid illness, (3) presence of stubborn cough, (4) absence of chest adventitious sounds, (5) no sputum or no identified aetiological agent by rapid diagnostic tests (Gram staining, urinary antigen tests and nasopharyngeal antigen test) and (6) a peripheral white blood cell (WBC) count of <10,000/ l. We evaluated whether the JRS scoring system could be adapted to the diagnosis of mild-to-moderate SARS-CoV-2 pneumonia. COVID-19, pneumonia, SARS-CoV-2, coronavirus disease, severe acute respiratory syndrome coronavirus 2.
- Subjects
COUGH; COVID-19; PNEUMONIA
- Publication
Respirology, 2022, Vol 27, Issue 1, p90
- ISSN
1323-7799
- Publication type
Article
- DOI
10.1111/resp.14173